OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300067$7.0455

Shanghai Anoky Group Co Ltd

Specialty ChemicalsVerified

Shanghai Anoky Group Co Ltd has a market capitalization of CNY 8.13 billion and a price-to-book ratio of 3.28, indicating that the market values the company at a premium to its book value. The company's liquidity position is assessed as medium, with a current ratio of 1.22, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. However, the company's free cash flow is negative at CNY -79.46 million, and its operating cash flow is only CNY 19.96 million, indicating a cash flow constraint. Profitability metrics show a challenging performance, with a net loss of CNY -63.24 million and an operating loss of CNY -79.46 million. The return on equity is -2.55%, and the return on assets is -1.79%, both significantly below the industry median for specialty chemicals. The company's gross profit of CNY 84.03 million is modest relative to its revenue of CNY 1.01 billion, indicating a low-margin business model. The company's geographic and segment exposure is not disclosed in the available data, but the lack of segmental breakdown suggests a concentration risk in its operations. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.36, but its long-term debt of CNY 902.10 million represents a significant portion of its total liabilities. Looking ahead, the company's revenue is expected to remain under pressure, with a negative operating income and declining profitability. The capital expenditure of CNY -102.45 million indicates ongoing investment, but the negative free cash flow suggests that these investments are not yet generating returns. The company's dilution risk is assessed as low, with no near-term pressure from share issuance or dilutive events. Recent filings and transcripts do not provide specific details on strategic initiatives or operational changes, but the company's financial performance suggests a need for cost optimization and margin improvement. The company's EBITDA is negative at CNY -63.24 million, and its enterprise value to EBITDA ratio is -113.63, indicating a lack of earnings power and a high valuation multiple.

30-day price · 300067(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyShanghai Anoky Group Co Ltd
Ticker300067.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Shanghai Anoky Group Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Shanghai Anoky Group Co Ltd has a market capitalization of CNY 8.13 billion and a price-to-book ratio of 3.28, indicating that the market values the company at a premium to its book value. The company's liquidity position is assessed as medium, with a current ratio of 1.22, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. However, the company's free cash flow is negative at CNY -79.46 million, and its operating cash flow is only CNY 19.96 million, indicating a cash flow constraint. Profitability metrics show a challenging performance, with a net loss of CNY -63.24 million and an operating loss of CNY -79.46 million. The return on equity is -2.55%, and the return on assets is -1.79%, both significantly below the industry median for specialty chemicals. The company's gross profit of CNY 84.03 million is modest relative to its revenue of CNY 1.01 billion, indicating a low-margin business model. The company's geographic and segment exposure is not disclosed in the available data, but the lack of segmental breakdown suggests a concentration risk in its operations. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.36, but its long-term debt of CNY 902.10 million represents a significant portion of its total liabilities. Looking ahead, the company's revenue is expected to remain under pressure, with a negative operating income and declining profitability. The capital expenditure of CNY -102.45 million indicates ongoing investment, but the negative free cash flow suggests that these investments are not yet generating returns. The company's dilution risk is assessed as low, with no near-term pressure from share issuance or dilutive events. Recent filings and transcripts do not provide specific details on strategic initiatives or operational changes, but the company's financial performance suggests a need for cost optimization and margin improvement. The company's EBITDA is negative at CNY -63.24 million, and its enterprise value to EBITDA ratio is -113.63, indicating a lack of earnings power and a high valuation multiple.
Key takeaways
  • The company is valued at a premium to book value, but its financial performance is weak, with negative net and operating income.
  • The company's liquidity is moderate, but its free cash flow is negative, indicating a cash flow constraint.
  • The company's profitability is below industry norms, with a negative return on equity and return on assets.
  • The company's capital structure is relatively conservative, but its long-term debt is a significant portion of its liabilities.
  • The company's growth trajectory is uncertain, with no clear signs of improvement in profitability or cash flow.
  • The company's dilution risk is low, but its financial performance suggests a need for cost optimization and margin improvement.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.01B
Gross profit$84.0M
Operating income-$79.5M
Net income-$63.2M
R&D
SG&A
D&A
SBC
Operating cash flow$20.0M
CapEx-$102.4M
Free cash flow-$79.5M
Total assets$3.54B
Total liabilities$1.06B
Total equity$2.48B
Cash & equivalents
Long-term debt$902.1M
Valuation
Market price$7.04
Market cap$8.13B
Enterprise value$9.03B
P/E
Reported non-GAAP P/E
EV/Revenue9.0
EV/Op income
EV/OCF452.4
P/B3.3
P/Tangible book3.3
Tangible book$2.48B
Net cash-$902.1M
Current ratio1.2
Debt/Equity0.4
ROA-1.8%
ROE-2.5%
Cash conversion-32.0%
CapEx/Revenue-10.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300067Activity
Op margin-7.9%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-6.3%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin8.4%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-10.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity36.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 01:17 UTCJob: fbecd493